NAUT nautilus.bio Expected net earnings per share growth this year
Nautilus Biotechnology (NAUT) is currently focused on research, awaiting an influx of funds following the market launch of its products. The annual earnings per share growth rate reflects current market dynamics, where the -3.20 level indicates the parameter's status. Nautilus Biotechnology is developing a unique tool for ultra-precise protein study, relying on a robust network of microfluidic component suppliers to ensure stable laboratory operations.
Analytical breakdowns and data insights for company nautilus.bio (NAUT)
- market value and analyst target forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and solvency information:
- net income and valuation multiples indicators:
NAUT - Net Profit|Expected Net Income Nautilus Biotechnology|NAUT - Price to Earnings Ratio|Price to Future Earnings Ratio Nautilus Bio|NAUT - Price/Earnings to Growth Ratio|Company Value to EBITDA NAUT|NAUT - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Nautilus Biotechnology|NAUT - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months nautilus.bio|NAUT - Earnings growth in current year|Net earnings per one share growth forecast for next year Nautilus Biotechnology
- sales volume and revenue information:
Summary company analysis:Nautilus Biotechnology Inc - NAUT
Nautilus Biotechnology (NAUT) is developing high-tech proteomics for the pharmaceutical sector and R&D. This indicator captures the year-over-year dynamics of earnings per share, revealing the actual efficiency of the business capitalization. By analyzing the annual earnings per share trend, an investor assesses the stability of cash flows and the issuer's solvency. The stability of the curve confirms the company's ability to service its debt, while a positive vector indicates the commercial success of the platform.
Direct competitors
Tempus Labs (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen Group|Isis Pharmaceuticals (IONS) - Expected net earnings per share growth this year|Net earnings per share growth this year RGEN (Repligen Corporation)|RNA (aviditybiosciences.com) - Earnings per share increase in current year|Earnings growth in current year CRSP (CRISPR Therapeutics)|GeneDx Holdings - Earnings per share growth in current year|Ultragenyx Pharma - Earnings growth in current year|Expected net earnings per share growth this year Beam Tx BEAM|Sarepta Therapeutics, Inc. (SRPT) - Earnings per share growth in current year|Earnings per share growth rate in current year twistbioscience.com (TWST)|Net earnings per share growth this year TXG|NTLA (Intellia Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year STOK|BLFS - Earnings per share growth rate in current year|Earnings growth in current year WVE (Wave Life Sciences)|MAZE - Net earnings per share growth this year|Sionna Therapeutics - Earnings growth in current year|Earnings per share increase in current year PRME (Prime Medicine Inc)|Taysha (TSHA) - Earnings per share growth in current year|Earnings per share growth this year QURE|Earnings per share growth in current year MeiraGTx Holdings plc|Earnings per share growth rate in current year regenxbio.com RGNX|Earnings per share growth in current year Solid Biosciences (SLDB)|Earnings per share growth in current year OCGN (Ocugen Inc)|Earnings per share growth in current year Pacific Biosciences of California PACB|Benitec Corp (BNTC) - Earnings per share growth rate in current year|Design Therapeutics - Earnings growth in current year|Net earnings per share change in current year rocketpharma.com (RCKT)|FDMT (4D Molecular Therapeutics, Inc.) - Net earnings per share growth this year|Earnings per share growth rate in current year Lexeo Therapeutics, Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Earnings per share growth this year EDIT (Editas Corp)|Earnings growth in current year SLN|Earnings growth in current year proqr.com (PRQR)|Codexis - Net earnings per share growth this year|Earnings growth in current year Sangamo Therapeutics Inc. SGMO|MGX: Net earnings per share growth this year|precisionbiosciences.com - Net earnings per one share growth for the current year|GBIO: Earnings growth in current year|Earnings per share growth this year BOLD|Earnings per share growth in current year Exicure Inc.|Earnings per share growth this year IMNN (Celsion Corporation)|Earnings growth in current year PHIO|Earnings growth in current year mustangbio.com (MBIO)|Earnings per share growth in current year TransCode Therapeutics, Inc. RNAZ|BNGO: Earnings per share growth this year|Applied DNA Sciences, Inc. - Earnings growth in current year|BLUE - Earnings growth in current year|IPA (immunoprecise.com) - Net earnings per share growth this year|Omega Therapeutics Corp (OMGA) - Earnings growth in current year|Net earnings per share growth this year OMIC|RGLS (regulusrx.com) - Net earnings per one share growth for the current year|Earnings growth in current year SYRS|Expected net earnings per share growth this year Telesis Bio Inc.|Earnings per share growth in current year TRACON TCON|Unity Biotechnology, Inc - Earnings per share growth in current year
